接下来就是按年调整，_老虎社区_美港股上老虎

欲山行
06-17 22:46

接下来就是按年调整，医药数据没几年是体现不出来的，而且风险极大。按年调整的话，国内这一波炒作的公司大部分都得腰斩起步，因为都是夸大的，只有极少数几家能得到验证跑出来。 $三生制药(01530)$ $荣昌生物(09995)$ $石药集团(01093)$ $中国生物制药(01177)$

# 创新药再迎利好！这次回调到位，上车哪家？

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":447145214140576,"tweetId":"447145214140576","gmtCreate":1750171566625,"gmtModify":1750171570132,"author":{"id":10000000000010488,"idStr":"10000000000010488","authorId":10000000000010488,"authorIdStr":"10000000000010488","name":"欲山行","avatar":"https://static.tigerbbs.com/e460befb8b73628d17452d4795753dfd","vip":8,"userType":8,"introduction":".","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":124,"starInvestorFlag":false},"themes":[{"themeId":"5295300d7a5d43469f7e004a8a52759a","categoryId":"d316d8bd4a714fab9ea15fd7157c45e7","name":"创新药再迎利好！这次回调到位，上车哪家？","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":5295300d7a5d43469f7e004a8a52759a}&rnconfig={\"headerBarHidden\": true}","description":"6月16日，创新药又迎来利好，符合要求的创新药临床试验， 申请审评审批时限，有望由60个工作日缩短为30个工作日。今年，三生制药、石药集团、中国生物制药等企业的出海成果，引爆了创新药二级市场行情，【恒生医药ETF，年初至今大幅跑赢恒生指数、恒生科技指数，沉寂已久的医药板块，能否迎来自己的“Deepseek”时刻？回调到位，你会上车哪一家？】","image":"https://static.tigerbbs.com/3b37f036cb04b5c9130f32429f11130a"}],"images":[],"coverImages":[],"html":"<html><head></head><body><p>接下来就是按年调整，医药数据没几年是体现不出来的，而且风险极大。按年调整的话，国内这一波炒作的公司大部分都得腰斩起步，因为都是夸大的，只有极少数几家能得到验证跑出来。 <a data-mention-id=\"01530\" class=\"teditor-mention\" data-mention-name=\"三生制药\" href=\"https://laohu8.com/S/01530\">$三生制药(01530)$</a>  <a data-mention-id=\"09995\" class=\"teditor-mention\" data-mention-name=\"荣昌生物\" href=\"https://laohu8.com/S/09995\">$荣昌生物(09995)$</a>  <a data-mention-id=\"01093\" class=\"teditor-mention\" data-mention-name=\"石药集团\" href=\"https://laohu8.com/S/01093\">$石药集团(01093)$</a>  <a data-mention-id=\"01177\" class=\"teditor-mention\" data-mention-name=\"中国生物制药\" href=\"https://laohu8.com/S/01177\">$中国生物制药(01177)$</a> </p></body></html>","htmlText":"<html><head></head><body><p>接下来就是按年调整，医药数据没几年是体现不出来的，而且风险极大。按年调整的话，国内这一波炒作的公司大部分都得腰斩起步，因为都是夸大的，只有极少数几家能得到验证跑出来。 <a data-mention-id=\"01530\" class=\"teditor-mention\" data-mention-name=\"三生制药\" href=\"https://laohu8.com/S/01530\">$三生制药(01530)$</a>  <a data-mention-id=\"09995\" class=\"teditor-mention\" data-mention-name=\"荣昌生物\" href=\"https://laohu8.com/S/09995\">$荣昌生物(09995)$</a>  <a data-mention-id=\"01093\" class=\"teditor-mention\" data-mention-name=\"石药集团\" href=\"https://laohu8.com/S/01093\">$石药集团(01093)$</a>  <a data-mention-id=\"01177\" class=\"teditor-mention\" data-mention-name=\"中国生物制药\" href=\"https://laohu8.com/S/01177\">$中国生物制药(01177)$</a> </p></body></html>","text":"接下来就是按年调整，医药数据没几年是体现不出来的，而且风险极大。按年调整的话，国内这一波炒作的公司大部分都得腰斩起步，因为都是夸大的，只有极少数几家能得到验证跑出来。 $三生制药(01530)$ $荣昌生物(09995)$ $石药集团(01093)$ $中国生物制药(01177)$","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/447145214140576","repostId":0,"isVote":1,"tweetType":1,"viewCount":122,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["01093","01530","09995","01177","SBHMY","688331"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":true,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":231,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}